2020ASCO小細胞肺癌和區域性晚期NSCLC進展之值得期待的臨床研究
(此處已新增醫療卡片,請到今日頭條客戶端檢視)摘要號TPS9080Phase I study of AMG 757, a half-life extended bispecific T-cell engager(HLE BiTE immun[…]
閱讀全文(此處已新增醫療卡片,請到今日頭條客戶端檢視)摘要號TPS9080Phase I study of AMG 757, a half-life extended bispecific T-cell engager(HLE BiTE immun[…]
閱讀全文